Integrated DNA Technologies and Aldevron Launch New Cas9 mRNA Solutions to Accelerate Path from Gene Editing Research to Development

Go back to Integrated DNA Technologies and Aldevron Launch New Cas9 mRNA Solutions to Accelerate Path from Gene Editing Research to Development
Danaher Corp. (NYSE: DHR) Delayed: 233.86 +9.62 (4.29%)
Previous Close $224.24    52 Week High $102.79 
Open $217.56    52 Week Low $75.71 
Day High $234.40    P/E 61.54 
Day Low $217.55    EPS $3.80 
Volume 8,899,587